Skip to main content
. 2018 Feb 21;7(3):139–144. doi: 10.1159/000485972

Fig. 2.

Fig. 2

Representative treatment response of case 1. Treatment with lenvatinib revealed remarkable tumor reduction 4 and 12 weeks after lenvatinib initiation compared with the baseline. Yellow arrow, tumor sites; red arrowhead, tumor invasion to the brachiocephalic artery.